VitiGam

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVitiGam
Drug Alias NameVitiligo patient-derived IgG (GammaCan/Life Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTyrosinase inhibitors
TargetsTyrosinase
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGammacan International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A